Principles of Transparency and Best Practice in Scholarly Publishing

Posted in February 20, 2023

As an open-access journal, Childhood Kidney Diseases (ChiKD) follows the Principles of Transparency and Best Practice in Scholarly Publishing (ver. 4, published September 15, 2022; https://doaj.org/apply/transparency) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).

JOURNAL CONTENT	JOURNAL PRACTICES	ORGANISATION	BUSINESS PRACTICES
1. Name of Journal 2. Website 3. Publishing Schedule 4. Archiving 5. Copyright 6. Licensing	7. Publication Ethics and Related Editorial Policies 8. Peer Review 9. Access	10. Ownership and Management 11. Advisory Body 12. Editorial Team and Contact Information	13. Author Fees 14. Other Revenue 15. Advertising 16. Direct Marketing

JOURNAL CONTENT

1. Name of journal

The official journal title is Childhood Kidney Diseases (abbreviated as Child Kidney Dis).

2. Website

The official website of our journal is https://chikd.org. The ChiKD team endeavors to make a high-quality website with accurate information and adherence to ethical and professional standards. It does not contain any misleading information, including any attempts to mimic other journal/publisher websites. Information for authors and readers is described in detail on the journal website. Key information can be found by clicking on the headings below.

• • Aims and Scope
• • Readership
• • Type of manuscript
• • Authorship criteria
• • ISSN: pISSN (2384-0242), eISSN (2384-0250)

3. Publishing Schedule

ChiKD is published twice a year (June 30 and December 31). Additional supplementary or special issues may also be published. The e-pub versions of all articles have been promptly seen after their acceptance on the journal homepage.

4. Archiving

ChiKD is available without a barrier through Korea Citation Index and is archived in the National Library of Korea in the event the journal is no longer published.

5. Copyright

All published papers become the permanent property of the Korean Society of Pediatric Nephrology. Copyrights of all published materials are owned by the Korean Society of Pediatric Nephrology and permission must be obtained for any commercial use of materials. Every author must sign the Transfer of Copyright Agreement forms. Copyright information is indicated on all published papers (HTML and PDF) and on the ChiKD website.

6. Licensing

ChiKD is an open-access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Licensing information is indicated on all published papers (HTML and PDF) and on the ChiKD website.

JOURNAL PRACTICES

7. Publication Ethics and Related Editorial Policies

ChiKD follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr). Our publication ethics and editorial policies are displayed on the Editorial policy tab of the journal homepage.

• Process for identification of and dealing with allegations of research misconduct

When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Research Ethics Committee of the ChiKD. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed. Anyone wishing to raise a concern or make a complaint about any aspect of being published in ChiKD journal, or working with our publishing partners may email chikd@chikd.org. Your complaint and appeal must be made in writing, not by telephone, and should be confined to the scientific and rational argument, based on facts over emotions.

8. Peer Review

ChiKD reviews all received materials. All papers are evaluated by a double-blind, peer-review process. Manuscripts are sent to the two (or more) most relevant investigators, who review the content. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 2 weeks after the reviewers agree to review a manuscript, and the reviewers’ comments will then be sent to the corresponding authors. Revised manuscripts must be submitted online by the corresponding author. Failure to resubmit the revised manuscript within 4 weeks of the editorial decision is regarded as a withdrawal. The editorial office should be notified if additional time is needed or if an author chooses not to submit a revision. The editorial committee makes decisions concerning editing, revision, and acceptance or rejection, and editing may include shortening an article, reducing the number of illustrations or tables, or changing the paper's format or the order of the manuscript. The editor selects referees, and the results of reviews will be classified as follows:
Accepted: The manuscript will be forwarded to the publisher without further corrections.
Minor revision: The author should address the comments from the reviewers, which will be confirmed by the reviewers.
Major revision: The author should address the comments from the reviewers and make the appropriate corrections for review by the reviewers.
Rejection: When one out of the two (or more) reviewers rejects the manuscript, the final decision is made by the editorial committee.
All articles in ChiKD include the dates of submission, revision, acceptance, and publication on their article page.

9. Access

ChiKD is an open-access journal. A free full-text service both in the XML and PDF formats is available immediately upon publication without an embargo period.

ORGANISATION

10. Ownership and Management

This journal is owned by the publisher, Korean Society of Pediatric Nephrology (http://www.kspn.org). The full names and affiliations of the members of the journal management team are displayed on the About (Managing team) tab of the journal homepage.

11. Advisory Body

The governing body is the journal's editorial board (http://www.chikd.org/about/editorial.php). All editorial board members' names and affiliations are disclosed, and their detailed information can be accessed via links to their ORCID, Research ID, and Scopus ID profiles.

12. Editorial Team and Contact Information

Editorial Team: The full names and affiliations of the journal’s editors are displayed on the About (Editorial board) tab of the journal homepage. All the members are responsible to improve the scientific quality of the journal and to implement an editorial policy approved by the editorial board.
Contact Information: The contact information for the editor-in-chief and the editorial office is on the About (Contact us) tab.

BUSINESS PRACTICES

13. Author Fees

There are no author submission fees or other publication-related charges. All cost for the publication process is supported by the publisher. ChiKD is a so-called platinum open-access journal that does not charge author fees.

14. Other Revenue

Revenue sources of this journal are from the support of the publisher (the Korean Society of Pediatric Nephrology), Korean Government’s support, and advertising rates.

15. Advertising

We accept advertising and sponsorship for its printed journal according to the following principles:
Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies. We reserve the right to decline or cancel any advertisement at any time. Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.

16. Direct Marketing

Journal propagation has been done through the journal website and the distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.

In addition, we declare that these principles acknowledge the responsibility of publishers and editors in promoting accessibility, diversity, equity, and inclusivity in all aspects of publication. Editorial decisions are based solely on scholarly merit, and should not be influenced by the authors' nationality, ethnicity, political beliefs, race, or religion. ChiKD is committed to ensuring that its policies do not create an exclusionary environment and will regularly evaluate them for inclusiveness.